A wide array of genomic differences exists between closely related species, ranging from point mutations to changes in the number of chromosome complements carried by the organism. Processes of gene duplication are in fact considered to be one of the key mechanisms for biological innovation (Wapinski et al., 2007 and references therein) , allowing an organism to "tinker" with a protein already imbued with biological functions (such as protein-protein interaction domains or enzymatic activity) rather than assembling a stable protein sequence de novo (Ohno, 1970) . Examination of differences between related species offers a glimpse at the history of evolutionary processes, but monitoring evolution in a test tube allows deeper exploration of these processes as they occur. Evolution of cells in vitro allows the fitness effects of each genomic change to be followed and the multiple mechanisms that cells use to overcome the same environmental obstacles to be identified (Elena and Lenski, 2003) . In this issue, Rancati et al. (2008) find that large-scale changes in ploidy are the first steps of the process by which the budding yeast, Saccharomyces cerevisiae, adapts to the loss of MYO1, a gene encoding the myosin II motor protein that is crucial for normal cytokinesis.
During cell division in budding yeast, the mother and daughter cell are separated by a narrow bud neck. Myo1 is required at cytokinesis for the involution of the bud neck and for normal formation of the septum structure that divides the mother and the daughter cell. To analyze how yeast adapt to the loss of Myo1, Rancati and colleagues generated haploid yeast cells that lack the MYO1 gene (myo1∆). Although the loss of MYO1 typically has lethal effects due to the disruption of cytokinesis, the authors were able to isolate a few surviving myo1∆ cells and propagate them for ~400 generations in 45 independent lines to allow for the emergence of spontaneous mutant cells that compensate for the lack of MYO1. A number of these strains, called e-strains ("evolved" strains), emerge from this selection. But how do these yeast cells manage to carry out cytokinesis despite the loss of a major motor protein? By characterizing a variety of physical phenotypes in these strains, the authors discover that the e-strains find alternative ways to form septa and categorize them into three different classes based on this process. Messenger RNA (mRNA) expression profiling further hints at the molecular mechanisms driving cytokinesis in these yeast strains. For example, one e-strain class exhibits a thickened cell wall at the septum, which correlates with upregulation of genes for cell wall biogenesis. This suggests that boosting production of the cell wall at the bud neck is sufficient to eventually force formation of a complete septum by a sort of mass action, even without a Myo1-dependent contractile ring. These results indicate that when faced with strong selective pressure due to the failure of a key cellular process, yeast find different ways to solve the same basic problem. However, it should be noted that (as one might expect) even the fittest e-strains are less fit than wild-type cells. Interestingly, although the fittest strains almost manage to recover normal cytokinesis rates, they are hindered by an increased level of cell death, suggesting that the speed of cytokinesis is recovered at the cost of reliability of the process.
Gene duplication provides an organism with a rich source of genetic material for tinkering by selection during evolution. In this issue, Rancati et al. (2008) report that extensive polyploidy and aneuploidy are the initial evolutionary changes in yeast selected in vitro to overcome defects resulting from the loss of a myosin II protein crucial for normal cytokinesis.
Perhaps the most interesting finding is the genomic changes that drive these new pathways to cytokinesis. In contrast to many previous laboratory evolution studies marked by genomic rearrangements and point mutations as dominant evolutionary factors (Dunham et al., 2002; Elena and Lenski, 2003) , Rancati et al. find that most of the e-strains (including ten of the fittest) exhibit polyploidy (an increased DNA content) ( Figure 1 ). Further, most of the strains also show aneuploidy (gain or loss of specific chromosomes). Why are these types of genomic changes so common in this system, and are they beneficial in solving the problems facing the cells? For polyploidy, the answer to the first question is probably related to the nature of the defect being suppressed-a failure in cytokinesis results in the accumulation of multiple nuclei in one undivided cell; nuclear fusion and thus polyploidization are likely to follow. But is polyploidy useful? The prevalence of polyploidy in nature, particularly in plants, suggests that it sometimes can be (Otto, 2007) . Rancati et al.'s study showing that increased ploidy aids in the emergence of fitter yeast strains supports this notion. They find that diploid strains lacking MYO1 compensate for the loss of the motor protein more rapidly than do haploid strains, suggesting that polyploidization in e-strains provides a more rapid path to adequate cytokinesis. The authors speculate that polyploidization is necessary to allow the loss or gain of specific chromosomes, resulting in the aneuploidy observed in the fittest e-strains. Another interesting possibility is based on simple geometry-in general, polyploidy increases cell size, thus altering the surface area to volume ratio of the cell. As cytokinesis is fundamentally a geometrically constrained process, it seems plausible that altered membrane curvature or surface area to volume ratio in polyploid cells could aid the separation of the mother and daughter cells.
What about the role of aneuploidy? In human tetraploid cells, aneuploidy occurs at significantly increased rates (Ganem et al., 2007) , again potentially as a consequence of the physical changes that result when cells increase their ploidy and volume (Storchova et al., 2006) . However, the increase in aneuploidy seen in the yeast strains could also be due to the very short evolutionary timeframe of these experiments. Four hundred generations is barely enough time for a cell to accumulate a handful of point mutations with subtle effects. In contrast, acquisition of aneuploidy leads to dramatic changes in the ratios of cellular components, providing giant leaps across the fitness landscape (Torres et al., 2008) . In other words, aneuploidy likely provides the fastest way (that is, the most likely route to occur in a small population over a short time period) for a cell to achieve dramatic alterations in the regulation of any given pathway. Targeted duplication of a single gene is very unlikely over these timescales ( Figure  1) .
Although aneuploidy results in large-scale dosage changes in many genes, the authors suggest that these gross alterations in ploidy are being selected because they increase dosage of specific genes. Rancati and colleagues identify genes whose duplication is sufficient to enhance the fitness of myo1∆ yeast. For example, careful examination of mRNA expression profiles of the e-strains suggests a specific role in one e-strain class for two factors that control the expression of cell wall components: the transcription factor Rlm1 and its activator Mkk2. Indeed, increasing the dosage of these two proteins alone improves the viability of myo1∆ yeast.
The new work provides a fascinating case of experimental evolution, where cells under strong selective pressure evolve adequate mechanisms of cytokinesis in the blink of an eye on the evolutionary timescale. The results suggest that the first steps in evolutionary change under massive selective pressure may be large-scale genomic alterations such as polyploidy and aneuploidy. This new genetic material may then be "finetuned" for the maintenance of a subset of Loss of the myosin II motor protein Myo1 in the budding yeast Saccharomyces cerevisiae normally results in lethal cytokinesis defects. Evolution of cells lacking MYO1 (myo1∆) in the laboratory over short time periods (~400 generations) results in a variety of yeast strains (e-strains) capable of adequate cytokinesis despite the loss of the motor protein. These strains have an increased genomic complement (polyploidy), as well as imbalances of particular chromosomes (aneuploidy). These large-scale genomic changes are unlikely to be the best possible solution to the challenge posed by Myo1 loss but may be the fastest solution over a short time period; small-scale genomic changes that can rescue the defect (such as specific gene duplications or point mutations) are unlikely to be generated in a small population. Thus, the dramatic changes observed in these yeast e-strains represent evolution in progress and, while imperfect, result in leaps across the fitness landscape. Further evolution of these strains might result in fine-tuning of the large-scale genomic changes, with excessive genomic material being trimmed to leave behind only the genes whose duplication or mutation are directly required to rescue the cytokinesis defect. necessary or useful duplicates (Kellis et al., 2004; Wapinski et al., 2007; DeLuna et al., 2008) with concomitant elimination of excess genetic baggage (Torres et al., 2008) . Besides providing an interesting snapshot of microbial evolution, these results are also relevant to cancer, as many tumors exhibit polyploidy and aneuploidy, reflecting a similar case of microevolution (Ganem et al., 2007) .
Classical cadherin adhesion receptors play critical roles in tissue organization. They mediate cell-cell recognition and morphogenesis during development and support cohesion in established tissues. Cadherin dysfunction can have detrimental effects such as promoting the metastasis of epithelial cancers. The diverse morphogenetic roles of cadherin receptors are not due solely to their intrinsic adhesive properties but also depend on the crosstalk between cadherins and key elements of the cytoplasmic machinery involved in signal transduction, membrane trafficking, and cytoskeletal organization. Although cadherins have long been thought to cooperate with the actin cytoskeleton, less attention has been paid to their capacity to interact with microtubules. Reporting in this issue, Meng et al. (2008) now identify a new cadherin-based protein complex in mammalian epithelial cells that can anchor microtubule minus ends to the zonula adherens (ZA) and is necessary for the biogenesis of this specialized junction.
Cadherins localize at epithelial cell-cell contacts in two patterns: the first comprises clusters and strands distributed throughout the lateral interface, and the second consists of an apically located linear band that is thought to mark the ZA, a specialized cell-cell junction (Kametani and Takeichi, 2007) . As little is known about how the ZA is generated and maintained, Meng and colleagues set out to identify new regulators of the ZA in mammalian cells by searching for proteins that bind to the cadherinassociated protein p120-catenin. They uncover a new interacting partner, a pleckstrin homology (PH) domain protein of unknown function called PLEKHA7 (PH domain-containing family A, member 7). Immunoprecipitation analysis reveals that PLEKHA7 interacts with the E-cadherin-catenin complex. PLEKHA7 specifically colocalizes with the pool of E-cadherin at the ZA in a p120-dependent manner. When p120 was depleted from the cells, or when binding of E-cadherin to p120 was disrupted by mutation, PLEKHA7 was no longer found at the cell junctions. Importantly, Meng et al. report that PLEKHA7 expression is needed for the maintenance of ZA integrity. Specifically, PLEKHA7 appears to promote the incorporation of cadherin clusters into the higher-order structure of the ZA. 
